ViS provides a game-changing analytics platform for the planning of clinical trials. Pharmaceutical trials are required for the evaluation of new medicines, and ViS’ collaborative
analytics radically improves cost-efficiency in the selection of research centers for trial participation.
ViS provides the only interactive map of global clinical research infrastructure, which achieves two objectives: I) allows trial planners to quickly find centers and make sense of vast amounts of comparative multi-dimensional analytics, going easily from the country level down to that of the center; and II) enables the more than 400,000 globally distributed research centers to securely and efficiently showcase their technical disease-specific capabilities to trial planners, while also connecting with collaborating centers that can lead to future projects.
Dan Zebrowski joined ThingWorx, Inc. in September 2012 and is responsible for overseeing all the day-to-day financial operations of the company as well as provide financial guidance and leadership on its strategic vision.
Prior to joining ThingWorx, Dan was Vice President Finance for Portico Systems in which he was also responsible for overseeing all the financial operations of the company as well as led strategic initiatives and provided strong leadership.
He helped manage and execute a $90MM sale of the company to McKesson Corporation in July 2011 and successfully transitioned the financial operations to the acquiring company. Dans other positions include Vice President Finance for Vis.Align, LLC, a leading high-technology mid-market solution services company. He has extensive experience in implementing fiscal processes and controls for software development firms.
Founder and CEO at ViS
Head of Trial Planning and Executive Director Europe at ViS
Head of Research Intelligence & Executive Director Asia at ViS
Head of Center Engagement and Executive Director LATAM at ViS
Head of Global Communications at ViS